SPOTLIGHT: Novartis sues Trimeris for patent infringement

The biopharmaceutical company Trimeris says it's being sued by Novartis for infringing a patent the Swiss drug maker got a month ago. The suit targets Fuzeon, Trimeris' HIV treatment developed in collaboration with Roche and approved in 2003. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.